Apotex Desmopressin Nasal Spray Recall: FDA Class II

Why it was recalled

Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.

Product description

Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0

Lot numbers, UPCs & expiration codes

Lot #: VM4231, Exp 06/30/2027

Where it was sold

U.S.A. Nationwide

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0510-2026
Classification: Class II
Status: Ongoing
Recall initiated: Apr 8, 2026
FDA report date: Apr 22, 2026
Quantity: N/A
Recall type: Voluntary: Firm initiated
Recalling firm: Apotex Corp.

Original FDA data

Every field from FDA enforcement report D-0510-2026, exactly as published.

Show all FDA fields

City: Weston
State: FL
Status: Ongoing
Country: United States
Event ID: 98736
Address: 2400 N Commerce Pkwy Ste 400
Code information: Lot #: VM4231, Exp 06/30/2027
Postal code: 33326-3253
Report date: Apr 22, 2026
Product type: Drugs
Recall number: D-0510-2026
Classification: Class II
Recalling firm: Apotex Corp.
Reason for recall: Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
Distribution pattern: U.S.A. Nationwide
Recall initiation date: Apr 8, 2026
Initial firm notification: E-Mail
Center classification date: May 1, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0510-2026, published Apr 22, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

Apotex Desmopressin Nasal Spray Recall

Summary